Assessment of antiphospholipid antibodies during the follow-up of patients after SARS-CoV-2 infection

dc.contributor.authorRosales-Castillo, Antonio
dc.contributor.authorMario Sabio, Jose
dc.contributor.authoraffiliation[Rosales-Castillo, Antonio] Hosp Univ Virgen Nieves, Serv Med Interna, Granada, Spain
dc.contributor.authoraffiliation[Mario Sabio, Jose] Hosp Univ Virgen Nieves, Unidad Enfermedades Autoinmunes Sistem, Granada, Spain
dc.date.accessioned2025-01-07T14:16:51Z
dc.date.available2025-01-07T14:16:51Z
dc.date.issued2022-05-13
dc.identifier.doi10.1016/j.medcli.2021.09.021
dc.identifier.essn1578-8989
dc.identifier.issn0025-7753
dc.identifier.pmid34895890
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.medcli.2021.09.021
dc.identifier.urihttps://hdl.handle.net/10668/26266
dc.identifier.wosID865797300008
dc.issue.number9
dc.journal.titleMedicina clinica
dc.journal.titleabbreviationMed. clin.
dc.language.isoes
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.page.number437-438
dc.publisherElsevier espana slu
dc.rights.accessRightsopen access
dc.titleAssessment of antiphospholipid antibodies during the follow-up of patients after SARS-CoV-2 infection
dc.typeletter
dc.type.hasVersionVoR
dc.volume.number158
dc.wostypeLetter

Files